What's New in Health and Life Sciences
News from the European Commission
EUROPA - Research and Innovation: What's New in Health and life sciences
EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
Human welfare is closely linked to the health of animals and the environment. An EU-funded joint research programme has been created to align developments in medicine, veterinary science and consumer health protection to tackle food-borne health threats in a more integrated way across Europe.
An EU-funded project has made recommendations to protect the rights of intersex people and prevent unnecessary, non-consensual medical interventions. This could strengthen European efforts to support sexual minorities.
EU-funded researchers are applying innovative techniques to detect early-warning signs of some of the most widespread and deadly diseases in Europe, enabling underlying health conditions to be treated sooner and more effectively, and ultimately saving lives.
Graphene, an atomically thin lattice of carbon, has many exceptional properties. An EU-funded project is developing ways to use this unique nanomaterial efficiently in novel optical technologies with potential applications in medical imaging, biosensing, signal processing and computing.
EU-funded researchers have created the first-ever full simulation of the growth of the lens within the eye of a mouse. It has given insights into how the lens develops and the formation of cataracts.
An EU- and industry-funded project has built an extensive public-private network to speed up the development of treatments to combat antibiotic-resistant bacteria that cause infections in intensive care units, helping address a major issue for hospitals.
Microfluidic bioreactors allow chemical reactions to take place on a very small scale, saving time, money and materials. An EU-funded project has developed microfluidic bioreactor technologies that could lead to a wide range of applications, including innovative medicines.
As more and more people travel and global warming paves the way for diseases to spread, human health and welfare are no longer the preserve of single countries, regions or even continents. European researchers teamed up with African partners to bridge the gap in biomedical research and biobanking practices between the regions. Its biobank-in-a-box is now ready to be unwrapped.